Tuberculosis Clinical Registry in Europe
ConditionTuberculosis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorResearch Center Borstel
About this trial
The TBnet registry is a multinational, prospective tuberculosis registry established by the Tuberculosis Network European Trialsgroup (TBnet e.V.) to collect and analyze long-term data from TB patients across Europe. Its purpose is to centralize data on TB epidemiology, prevention, diagnosis, and treatment to improve care, support research, and ultimately help eliminate TB. The registry captures risk factors, diagnostic details (e.g., microbiology, imaging, drug resistance), treatment data, side effects, outcomes, and late complications.
Eligibility criteria
Qualifiers
Diagnosis of Tuberculosis
Age ≥ 18 years
Capacity to provide informed consent
Written informed consent to participate in the study
Disqualifiers
Lack of capacity to provide informed consent
Age < 18 years
Trial design
Treatments tested in this trial
- data collection
Treatment groups
1,000 Participants
are divided into 4 treatment groupsSponsors and collaborators
Research Center Borstel
Lead sponsor
European Society of Clinical Microbiology and Infectious Diseases
Collaborator
Tuberculosis Network European Trialsgroup (TBnet e.V.)
Collaborator
Source ClinicalTrials.gov